Isatuximab (anti-CD38) (SAR650984, hu38SB19) is an IgG1-derived monoclonal antibody that binds to a specific extracellular epitope of CD38 receptor with a kd of 0.12 nM.
[1] Meletios Dimopoulos, et al. Blood . 2021 Mar 4;137(9):1154-1165. [2] Swiss Public Assessment Report. Date: 7 May 2020.
















